Status:
UNKNOWN
Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement
Lead Sponsor:
Our Lady of the Lake Hospital
Collaborating Sponsors:
Louisiana State University Health Sciences Center in New Orleans
Conditions:
Salivary Duct
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Salivary duct stent placement is a common practice to maintain duct patency after salivary duct repair or interventional sialoendoscopy; procedures performed to manage salivary duct pathology such as ...
Eligibility Criteria
Inclusion
- All adult patients (18 years of age or older) who are undergoing salivary duct surgery and stent placement at Our Lady of the Lake Regional Medical Center
Exclusion
- Patients who are unwilling to consent to the study and/or to being placed in a randomized arm of either receiving post-operative antibiotics or not receiving post-operative antibiotics
- Patients with acute infections at the time of surgery
- Patients who are immunocompromised
- Patients who are recruited but then have early dislodgement of the stent
- Patients who do not complete their postoperative antibiotic therapy due to intolerance or antibiotic side effects. However, data on these patients will be recorded to provide an observational results that will support the need for this investigation on antibiotic use.
- Patients who are in the non-post operative antibiotic arm but choose to put themselves on antibiotics without consultation from the physician
Key Trial Info
Start Date :
June 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03333408
Start Date
June 15 2018
End Date
December 31 2024
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States, 70808